Related Experiment Video
Updated: Jul 28, 2025

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
Detection of Burkholderia pseudomallei with CRISPR-Cas12a based on specific sequence tags
Jia-Xin Zhang1, Jian-Hao Xu1, Bing Yuan1
1State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Abstract:
Melioidosis is a bacterial infection caused by Burkholderia pseudomallei (B. pseudomallei), posing a significant threat to public health. Rapid and accurate detection of B. pseudomallei is crucial for preventing and controlling melioidosis. However, identifying B. pseudomallei is challenging due to its high similarity to other species in the same genus. To address this issue, this study proposed a dual-target method that can specifically identify B. pseudomallei in less than 40 min. We analyzed 1722 B. pseudomallei genomes to construct large-scale pan-genomes and selected specific sequence tags in their core genomes that effectively distinguish B. pseudomallei from its closely related species. Specifically, we selected two specific tags, LC1 and LC2, which we combined with the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR associated proteins (Cas12a) system and recombinase polymerase amplification (RPA) pre-amplification. Our analysis showed that the dual-target RPA-CRISPR/Cas12a assay has a sensitivity of approximately 0.2 copies/reaction and 10 fg genomic DNA for LC1, and 2 copies/reaction and 20 fg genomic DNA for LC2. Additionally, our method can accurately and rapidly detect B. pseudomallei in human blood and moist soil samples using the specific sequence tags mentioned above. In conclusion, the dual-target RPA-CRISPR/Cas12a method is a valuable tool for the rapid and accurate identification of B. pseudomallei in clinical and environmental samples, aiding in the prevention and control of melioidosis.
Insights
A new dual-target method rapidly and accurately detects Burkholderia pseudomallei (B. pseudomallei), the cause of melioidosis. This RPA-CRISPR/Cas12a assay aids in timely diagnosis and control of this significant public health threat.
Area of Science:
- Microbiology and Infectious Diseases
- Molecular Diagnostics
- Genomics
Background:
- Melioidosis, caused by Burkholderia pseudomallei (B. pseudomallei), is a serious public health concern.
- Accurate and rapid detection of B. pseudomallei is critical for melioidosis management.
- Distinguishing B. pseudomallei from closely related species poses a diagnostic challenge.
Purpose of the Study:
- To develop a novel dual-target method for specific and rapid identification of B. pseudomallei.
- To enable early detection of B. pseudomallei in clinical and environmental samples.
- To improve the prevention and control strategies for melioidosis.
Main Methods:
- Genome analysis of 1722 B. pseudomallei strains to construct large-scale pangenomes.
- Selection of specific sequence tags (LC1 and LC2) from core genomes for differentiation.
- Integration of selected tags with recombinase polymerase amplification (RPA) and CRISPR-Cas12a system.
Main Results:
- The dual-target RPA-CRISPR/Cas12a assay achieved high sensitivity: 0.2 copies/reaction (LC1) and 2 copies/reaction (LC2).
- Detection limits were as low as 10 fg genomic DNA for LC1 and 20 fg for LC2.
- The method accurately detected B. pseudomallei in human blood and moist soil samples within 40 minutes.
Conclusions:
- The dual-target RPA-CRISPR/Cas12a method offers a rapid and accurate tool for B. pseudomallei identification.
- This assay is valuable for both clinical diagnostics and environmental surveillance of B. pseudomallei.
- The developed method significantly aids in the timely prevention and control of melioidosis.
Related Concept Videos
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The Antiviral System of Bacteria and Archaea: CRISPR

